- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00673907
HIPWOODS - Health Effects Related to Exposure to Particle Pollution From Woodburning Stoves (HIPWOODS)
Health Effects Related to Exposure to Particle Pollution From Woodburning
The study intends to focus on health effects and symptoms related to particle exposure from wood burning stoves
The objective is to determine whether moderate exposure to particles from wood smoke in a real life situation causes an systemic inflammatory response in peripheral blood or in lower airways. 24 healthy subjects (normal healthy subjects and mild asthmatics to study the asthmatic response) is selected for the study. A randomized double blind crossover procedure will be followed with a PM exposure concentration of 200ug/m3, 400ug/m3 or clean air as the control exposure. Exposure will take place in a climate chamber using wood burning in an appropriate wood stove.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Public health is concerned with the physical, mental and environmental health of communities and populations at risk for disease and injury. Generally, the determination of health effects associated with indoor and outdoor exposures is difficult since documented cause-and-effect relationships are rare and the exposure and dosage data is sparse. Information about actual human exposure to different types of pollution has several important uses, including informing risk assessments, helping predict the potential consequences of exposures, and developing exposure criteria for regulations and other public policy guidance.
Wood-burning stoves have been a popular heating source for decades. Unfortunately, wood-burning stoves can emit substantial quantities of pollutants to outdoor and indoor air. Among the pollutants are: chlorinated dioxin, carbon monoxide, methane, volatile organic compounds (VOC), nitrogen oxides, polycyclic aromatic hydrocarbons (PAH), and fine particulate matter (PM10, PM2.5, fine and ultra fine particles). Recent studies indicate that the use of wood-burning stoves for heating of dwellings is one of the important outdoor particle sources [Glasius et al. 2004] in residential district in Denmark. This has resulted in an increase in public exposure to indoor and outdoor wood smoke related pollutants, which has prompted widespread concern about the adverse human health consequences that may be associated with wood smoke exposure.
Air pollution is a major aggravation of respiratory symptoms and disease. Effects are decreases in pulmonary function and evidence of inflammation as well as suggestions of increases in chronic respiratory disease. Orozco-Levi et al. (2006) showed strong association between wood smoke exposure and obstructive pulmonary disease. Several studies have shown that especially the small particles, has an effect on airways, and that asthmatic subjects may be the group at greatest risk from air pollutants. The awareness of the impact of airborne particles, particularly fine and ultra fine particles, on health is growing. In recent years, exposure to fine and ultra fine airborne particles has been identified as an important factor affecting human health [Seaton et al., 1995; Schwartz et al., 1996; Oberdörster et al., 1994; Alvin et al., 2000]. Several researchers hypothesize that an increased mortality is associated with the particle levels prevailing in urban air [Jamriska et al., 1999; Dockery et al., 1993]. Mølhave et al (2000; 2005) have suggested that reactive short-lived compounds resulting from reactions between ozone and particulate matter cause indoor air quality complaints and objective health effects such as impaired lung functions.
Particulate air pollution is also known to increase cardiovascular morbidity and mortality. Still the existing scientific knowledge and foundation for evaluating the underlying mechanisms and influence of particle exposure on human immune system are limited. Wood smoke particles, at levels that can be found in smoky indoor environments, seem to affect inflammation. Barregard et al observed a significant increase in S-Amyloid and Faktor VIII/vWf after 0, 3 and 20 hours of exposure to wood smoke. After 20 hours also and increase in Faktor VIII was registred. Surpise-lingly, an IL.-6 decrease was observed after 3 hours. [Barregard et al, 2006]. The particles may also act by increasing blood coagulation factors [Seaton et al 1995]. Both effects may be involved in the mechanisms whereby particulate air pollution affects cardiovascular morbidity and mortality.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Aarhus C, Denmark, 8000
- Institute of Environmental and Occupational Medicine , Institute of Public Health , The Faculty of Health Sciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Twenty-four, non-smoking atopic volunteers with normal lung function and bronchial reactivity are recruited for the study. Atopy is determined by skin-prick testing to common aeroallergens.
Exclusion Criteria:
- Smokers, pregnant women and other subjects with current or previous diseases, which could involve a risk for the subject or possibly influence the outcome measurements, will be excluded from the study.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Sham Comparator: 1
Clean air
|
Subjects are exposed at rest to the exposures for 3 h in our climate chamber
|
Experimental: 2
Wood smoke particle concentration of 200 ug/m3
|
Subjects are exposed at rest to the exposures for 3 h in our climate chamber
|
Experimental: 3
Wood smoke particle concentration of 400 ug/m3
|
Subjects are exposed at rest to the exposures for 3 h in our climate chamber
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Different Inflammation Biomarkers
Time Frame: Baseline and follow up measurement after exposure 0 hours post, a 6 hours post and 20 hours post.
|
Baseline and follow up measurement after exposure 0 hours post, a 6 hours post and 20 hours post.
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Baseline and follow up measurements are: spirometry, exhaled breath condensate, nasal lavage, nasal patency, blood sampling and symptoms.
Time Frame: Baseline and follow up measurement after exposure 0 hours post, a 6 hours post and 20 hours post.
|
Baseline and follow up measurement after exposure 0 hours post, a 6 hours post and 20 hours post.
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Torben Sigsgaard, Professor, Department of Environmental and Occupational Medicine , Institute of Public Health , The Faculty of Health Sciences
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2104-05-0003
- Projekt nr: 0502-
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Systemic Inflammation
-
Lawson Health Research InstituteCompletedSepsis | Systemic InflammationCanada
-
University of EdinburghUmeå UniversityCompletedSystemic Inflammation | Respiratory InflammationSweden
-
Assistance Publique - Hôpitaux de ParisCompletedSystemic Inflammation | BiomarkerFrance
-
University of Campania "Luigi Vanvitelli"CompletedBirth Weight | Systemic Inflammation Markers | Combined Systemic Inflammatory IndicesItaly
-
University of SalzburgCompletedSystemic InflammationAustria
-
Alloksys Life Sciences B.V.Aix ScientificsRecruitingSystemic Inflammation | Cardiopulmonary-bypassAustralia, Austria, Belgium, Germany, Italy, Malaysia, Portugal, Netherlands, Russian Federation, Singapore, Spain
-
Simon Fraser UniversityCompletedEndothelial Dysfunction | Systemic InflammationCanada
-
Rigshospitalet, DenmarkCompletedSepsis | Systemic InflammationDenmark
-
Simon Fraser UniversityUniversity of British Columbia; Health Canada; Ministry of Environment, British...CompletedOxidative Stress | Systemic Inflammation | Endothelial FunctionCanada
-
Northumbria UniversityEvolva SACompletedCognitive Change | Mood | Systemic InflammationUnited Kingdom
Clinical Trials on Wood smoke particles
-
University of North Carolina, Chapel HillNational Institute of Environmental Health Sciences (NIEHS)RecruitingAllergic Asthma | Airway InflammationUnited States
-
University of North Carolina, Chapel HillNational Institute of Environmental Health Sciences (NIEHS); Environmental...CompletedResponse of Viral Infection to WoodsmokeUnited States
-
Umeå UniversityUnknownPulmonary Inflammation | CytotoxicitySweden
-
University of North Carolina, Chapel HillEnvironmental Protection Agency (EPA)RecruitingHealthyUnited States
-
University of California, San FranciscoCompletedCardiovascular DiseaseUnited States
-
Washington State UniversityNational Institute of Nursing Research (NINR)Completed
-
Hadassah Medical OrganizationCompleted
-
University of Southern CaliforniaSouthern California NIOSH Education and Research CenterCompleted
-
University of AarhusAarhus University Hospital; University of CopenhagenCompletedAsthma | DNA Damage | Lung Function Decreased | Cooking | Candle Burning | Subjective HealthDenmark
-
Michigan State UniversityUniversity of Michigan; Wake Forest University Health Sciences; Babes-Bolyai...CompletedUsual Care | Telemedicine: Smoking Cessation App Only | Telemedicine: Smoking Cessation Counseling | Telemedicine: App + CounselingRomania